- Home
- BLCO vs IDCC Comparison
BLCO vs IDCC Comparison
Compare BLCO & IDCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- IDCC
- Stock Information
- Founded
- BLCO 1853
- IDCC 1972
- Country
- BLCO Canada
- IDCC United States
- Employees
- BLCO N/A
- IDCC N/A
- Industry
- BLCO Ophthalmic Goods
- IDCC Multi-Sector Companies
- Sector
- BLCO Health Care
- IDCC Miscellaneous
- Exchange
- BLCO Nasdaq
- IDCC Nasdaq
- Market Cap
- BLCO 5.6B
- IDCC N/A
- IPO Year
- BLCO 2022
- IDCC N/A
- Fundamental
- Price
- BLCO $14.14
- IDCC $210.04
- Analyst Decision
- BLCO Hold
- IDCC Hold
- Analyst Count
- BLCO 11
- IDCC 3
- Target Price
- BLCO $19.10
- IDCC $120.00
- AVG Volume (30 Days)
- BLCO 578.8K
- IDCC 378.8K
- Earning Date
- BLCO 04-30-2025
- IDCC 05-01-2025
- Dividend Yield
- BLCO N/A
- IDCC 0.90%
- EPS Growth
- BLCO N/A
- IDCC 58.40
- EPS
- BLCO N/A
- IDCC 12.07
- Revenue
- BLCO $4,791,000,000.00
- IDCC $868,516,000.00
- Revenue This Year
- BLCO $6.53
- IDCC N/A
- Revenue Next Year
- BLCO $5.64
- IDCC N/A
- P/E Ratio
- BLCO N/A
- IDCC $17.40
- Revenue Growth
- BLCO 15.56
- IDCC 58.03
- 52 Week Low
- BLCO $13.16
- IDCC $95.33
- 52 Week High
- BLCO $21.69
- IDCC $231.97
- Technical
- Relative Strength Index (RSI)
- BLCO 26.70
- IDCC 46.59
- Support Level
- BLCO $15.23
- IDCC $214.73
- Resistance Level
- BLCO $15.77
- IDCC $227.07
- Average True Range (ATR)
- BLCO 0.44
- IDCC 6.58
- MACD
- BLCO -0.05
- IDCC -0.98
- Stochastic Oscillator
- BLCO 11.82
- IDCC 21.67
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.